Common statins increase the risk of diabetes, discovers a new study
The researchers compared two of the most commonly prescribed drugs.
High cholesterol levels is very common, affecting 71 million Americans , according to Johns Hopkins Medicine. Certain lifestyle changes can help control "bad" cholesterol levels, including exercise and healthy diet, but drugs are also an option. Statins are among the most commonly prescribed drugs, working to block a substance your liver needs to make cholesterol and encourage your liver to Remove cholesterol of your blood, according to the Mayo clinic. There are different types of statins, but a recent study has revealed that a very common type could have an involuntary consequence. Read the rest to find out more about the link between a popular statin and diabetes.
In relation: The ozempic patient reveals "a new" atrocious "side effect .
The study compared Rosuvastatin and Atorvastatin.
A study published in Bmj Last month investigated Two widely used statins , Rosuvastatin (commonly marked like Crestor) and Atorvastatin (generally marked as lipitor), to determine their long -term efficiency and safety in adults with coronary coronary disease (CAD).
According to a Press release Describing the results, the drop in "bad" cholesterol levels (low density lipoproteins or LDL) is recommended for people with CAD, but very few studies have compared these two statins - described as "the most powerful two - Among these patients.
The study was carried out between September 2016 and November 2019, the researchers analyzing the data of 4,400 patients in 12 hospitals in South Korea.
The patients were assigned to random to take rosuvastatin or atorvastatin during the three -year period, investigators then examining the differences in number of deaths (of any cause), the rate of heart attacks, strokes of cerebral accidents and coronary revascularization (procedures that restore blood flow the heart), the press release said. Researchers also examined the admissions to the hospital due to heart failure, the main blood clots, cataract surgery, as well as the development of type 2 diabetes.
In relation: Heart medication recalled after a dangerous mixture of labels, the FDA warns . AE0FCC31AE342FD3A1346EBB1F342FCB
Patients under Rosuvastatin presented a higher risk of diabetes and cataract surgery.
Almost 88% of patients finished the test, without differences observed between rosuvastatin and atorvastatin in terms of death, heart attack, stroke and revascularization.
People under Rosuvastatin had average levels of LDL cholesterol lower average during the study compared to those of Atorvastatin, but they also had a higher risk of requiring cataract surgery (2.5% Against 1.5%) - and develop diabetes.
According to the press release, 7.2% of patients in the Rosuvastatin group developed diabetes, compared to 5.3% of the Atorvastatin group. The study also revealed that those who took Rosuvastatin also had a higher risk of developing diabetes which required anti -diabetic drugs (7.2% against 5.3%).
In relation: The new drug has people who lose 60 pounds on average, shows research - and it's not ozempic .
It was not the first study to connect Rosuvastatin and diabetes.
The authors of the study noted that the Jupiter 2008 test was the first to report an increased risk of diabetes in people taking rosuvastatin; However, the 2023 study was the first to examine the incidence of diabetes in patients taking Rosuvastatin against Atorvastatin.
Researchers have also noted that more research is necessary to determine whether the increase in diabetes and cataract surgery is "directly linked to the treatment of statins".
There were limits.
The authors of the study noted certain limits, including a limited pool of patients, which may have affected the results.
"Researchers recognize several study limitations, including the fact that only Asian participants were included in this trial, and the three -year study period may have been relatively short to find longer -term effects Two types of statins, "said the press release.
In this spirit, they warn that the results "should be interpreted with caution, and a more dedicated investigation with longer follow -up is justified".
In relation: For more information, register for our daily newsletter .
Best Life offers the most up -to -date information for high -level experts, new research and health agencies, but our content is not supposed to replace professional advice. Regarding the medication you take or any other health issue you have, always consult your health care provider directly.
